William E. Russell

10.7k total citations · 2 hit papers
90 papers, 6.3k citations indexed

About

William E. Russell is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, William E. Russell has authored 90 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 28 papers in Endocrinology, Diabetes and Metabolism and 24 papers in Surgery. Recurrent topics in William E. Russell's work include Liver physiology and pathology (20 papers), Diabetes Management and Research (16 papers) and Pancreatic function and diabetes (16 papers). William E. Russell is often cited by papers focused on Liver physiology and pathology (20 papers), Diabetes Management and Research (16 papers) and Pancreatic function and diabetes (16 papers). William E. Russell collaborates with scholars based in United States, Canada and United Kingdom. William E. Russell's co-authors include Robert J. Coffey, David C. Lee, Susan W. Sunnarborg, Nancy L. R. Bucher, Beverly J. Castner, Roy A. Black, Raymond J. Paxton, Mary C. Stevenson, Jacques J. Peschon and H L Moses and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

William E. Russell

86 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Essential Role for Ectodomain Shedding in Mammalian Development

1998 1.4k citations Jacques J. Peschon, Jennifer L. Slack et al. Science profile →
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

2011 428 citations Linda A. DiMeglio, Stephen E. Gitelman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William E. Russell United States	37	2.2k	1.7k	1.4k	1.3k	1.1k	90	6.3k
Mario Serio Italy	48	2.8k 1.3×	1.2k 0.7×	2.1k 1.5×	1.4k 1.1×	851 0.7×	151	8.2k
Yusuke Nakamura Japan	54	4.6k 2.1×	1.2k 0.7×	2.1k 1.5×	313 0.2×	1.8k 1.6×	160	10.4k
Susumu Satomi Japan	39	1.5k 0.7×	2.8k 1.6×	670 0.5×	631 0.5×	796 0.7×	215	5.7k
Marko Salmi Finland	66	4.7k 2.1×	1.0k 0.6×	1.9k 1.4×	317 0.2×	923 0.8×	202	10.7k
Hyoung Doo Shin South Korea	43	2.4k 1.1×	647 0.4×	674 0.5×	447 0.4×	1.6k 1.4×	307	7.3k
Hiroshi Nagura Japan	51	2.2k 1.0×	1.7k 1.0×	2.2k 1.6×	1.1k 0.9×	1.3k 1.2×	245	8.7k
Hiroyuki Takahashi Japan	31	3.0k 1.4×	592 0.3×	2.2k 1.6×	896 0.7×	1.5k 1.3×	156	7.7k
Naoyuki Kamatani Japan	51	2.8k 1.3×	905 0.5×	1.0k 0.7×	280 0.2×	1.5k 1.4×	179	8.9k
Zhiyong Guo China	39	2.3k 1.1×	763 0.4×	818 0.6×	807 0.6×	897 0.8×	126	5.6k
G. Adler Germany	44	1.9k 0.9×	3.3k 1.9×	2.3k 1.7×	416 0.3×	828 0.7×	204	6.8k

Countries citing papers authored by William E. Russell

Since Specialization

Citations

This map shows the geographic impact of William E. Russell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Russell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Russell more than expected).

Fields of papers citing papers by William E. Russell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Russell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Russell. The network helps show where William E. Russell may publish in the future.

Co-authorship network of co-authors of William E. Russell

This figure shows the co-authorship network connecting the top 25 collaborators of William E. Russell. A scholar is included among the top collaborators of William E. Russell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William E. Russell. William E. Russell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gitelman, Stephen E., Kimber M. Simmons, Jennifer L. Sherr, et al.. (2025). Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes. Diabetologia. 69(2). 330–342. 2 indexed citations

Wilson, Christopher, Jonathan M. Williams, Melissa A. Hilmes, et al.. (2025). Use of Teplizumab to Modulate Stage 2 Type 1 Diabetes in Two Individuals With Autoimmune Polyendocrine Syndrome 1. Diabetes Care. 49(1). 111–117.

Roden, Anja C., Edith M. Marom, Małgorzata Szołkowska, et al.. (2019). Case presentation and recommendations from the April 2019 ITMIG tumor board: an international multidisciplinary team. Mediastinum. 3. 41–41. 1 indexed citations

Virostko, John, Jonathan M. Williams, Melissa A. Hilmes, et al.. (2018). Pancreas Volume Declines During the First Year After Diagnosis of Type 1 Diabetes and Exhibits Altered Diffusion at Disease Onset. Diabetes Care. 42(2). 248–257. 77 indexed citations

Scheving, Lawrence A., Xiuqi Zhang, David W. Threadgill, & William E. Russell. (2016). Hepatocyte ERBB3 and EGFR are required for maximal CCl₄-induced liver fibrosis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 311(5). G807–G816. 30 indexed citations

Datye, Karishma A., Daniel J. Moore, William E. Russell, & Sarah S. Jaser. (2015). A Review of Adolescent Adherence in Type 1 Diabetes and the Untapped Potential of Diabetes Providers to Improve Outcomes. Current Diabetes Reports. 15(8). 51–51. 117 indexed citations

Buscariollo, Daniela L., Mario Davidson, Margo Black, et al.. (2012). Factors That Influence Parental Attitudes toward Enrollment in Type 1 Diabetes Trials. PLoS ONE. 7(8). e44341–e44341. 21 indexed citations

Bishop, Nick, Cheryl R. Greenberg, Mairead McGinn, et al.. (2011). Life-threatening hypophosphatasia (HPP): Results of up to two years bone-targeted Enzyme Replacement Therapy (ERT) in infants and young children. Bone. 48. S82–S82. 1 indexed citations

Sahakitrungruang, Taninee, Ningwu Huang, Meng Kian Tee, et al.. (2009). Clinical, Genetic, and Enzymatic Characterization of P450 Oxidoreductase Deficiency in Four Patients. The Journal of Clinical Endocrinology & Metabolism. 94(12). 4992–5000. 54 indexed citations

10.

Rothman, Russell L., Shelagh A. Mulvaney, Tom A. Elasy, et al.. (2008). Self-Management Behaviors, Racial Disparities, and Glycemic Control Among Adolescents With Type 2 Diabetes. PEDIATRICS. 121(4). e912–e919. 68 indexed citations

11.

Scheving, Lawrence A., Mary C. Stevenson, Xiuqi Zhang, & William E. Russell. (2008). Cultured rat hepatocytes upregulate Akt and ERK in an ErbB-2-dependent manner. American Journal of Physiology-Gastrointestinal and Liver Physiology. 295(2). G322–G331. 17 indexed citations

12.

Scheving, Lawrence A., et al.. (2006). The emergence of ErbB2 expression in cultured rat hepatocytes correlates with enhanced and diversified EGF-mediated signaling. American Journal of Physiology-Gastrointestinal and Liver Physiology. 291(1). G16–G25. 17 indexed citations

13.

Hinkle, C. Leann, Susan W. Sunnarborg, David R. Loiselle, et al.. (2004). Selective Roles for Tumor Necrosis Factor α-converting Enzyme/ADAM17 in the Shedding of the Epidermal Growth Factor Receptor Ligand Family. Journal of Biological Chemistry. 279(23). 24179–24188. 124 indexed citations

14.

Russell, William E., et al.. (2003). Humoral regulation of growth.. 277–303. 1 indexed citations

15.

Carver, Robert S., Mary C. Stevenson, Lawrence A. Scheving, & William E. Russell. (2002). Diverse expression of ErbB receptor proteins during rat liver development and regeneration. Gastroenterology. 123(6). 2017–2027. 90 indexed citations

16.

Scheving, Lawrence A. & William E. Russell. (2001). Insulin and heregulin-β1 upregulate guanylyl cyclase C expression in rat hepatocytes. Cellular Signalling. 13(9). 665–672. 3 indexed citations

17.

Schroeder, Friedhelm, Andrey V. Frolov, Olga Starodub, et al.. (2000). Pro-sterol Carrier Protein-2. Journal of Biological Chemistry. 275(33). 25547–25555. 50 indexed citations

18.

Peschon, Jacques J., Jennifer L. Slack, P. Linga Reddy, et al.. (1998). An Essential Role for Ectodomain Shedding in Mammalian Development. Science. 282(5392). 1281–1284. 1355 indexed citations breakdown →

19.

Russell, William E. & Nancy L. R. Bucher. (1983). Vasopressin modulates liver regeneration in the Brattleboro rat. American Journal of Physiology-Gastrointestinal and Liver Physiology. 245(2). G321–G324. 67 indexed citations

20.

Russell, William E.. (1975). Luteolysis induced in pigtail monkeys (Macaca nemestrina) with prostaglandin F2α, ICI 80996 and ICI 81008. Prostaglandins. 10(4). 163–183. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact